Results
|
|
13641.
|
|
|
|
13642.
|
|
|
|
13643.
|
Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis. [electronic resource] by
- Nakamura, T
- Ito, M
- Hashimoto, J
- Shinomiya, K
- Asao, Y
- Katsumata, K
- Hagino, H
- Inoue, T
- Nakano, T
- Mizunuma, H
Producer: 20160801
In:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 26
Availability: No items available.
|
|
|
13644.
|
Denosumab versus zoledronic acid in patients previously treated with zoledronic acid. [electronic resource] by
- Anastasilakis, A D
- Polyzos, S A
- Gkiomisi, A
- Saridakis, Z G
- Digkas, D
- Bisbinas, I
- Sakellariou, G T
- Papatheodorou, A
- Kokkoris, P
- Makras, P
Producer: 20160706
In:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 26
Availability: No items available.
|
|
|
13645.
|
|
|
|
13646.
|
The effect of laser therapy on the expression of osteocalcin and osteopontin after tooth extraction in rats treated with zoledronate and dexamethasone. [electronic resource] by
- Mergoni, Giovanni
- Vescovi, Paolo
- Sala, Roberto
- Merigo, Elisabetta
- Passerini, Pietro
- Maestri, Roberta
- Corradi, Domenico
- Govoni, Paolo
- Nammour, Samir
- Bianchi, Massimiliano G
Producer: 20160809
In:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 24
Availability: No items available.
|
|
|
13647.
|
|
|
|
13648.
|
Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy study. [electronic resource] by
- Misof, Barbara M
- Patsch, Janina M
- Roschger, Paul
- Muschitz, Christian
- Gamsjaeger, Sonja
- Paschalis, Eleftherios P
- Prokop, Eva
- Klaushofer, Klaus
- Pietschmann, Peter
- Resch, Heinrich
Producer: 20140904
In:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research vol. 29
Availability: No items available.
|
|
|
13649.
|
|
|
|
13650.
|
|
|
|
13651.
|
|
|
|
13652.
|
|
|
|
13653.
|
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model. [electronic resource] by
- Esser, Alison K
- Schmieder, Anne H
- Ross, Michael H
- Xiang, Jingyu
- Su, Xinming
- Cui, Grace
- Zhang, Huiying
- Yang, Xiaoxia
- Allen, John S
- Williams, Todd
- Wickline, Samuel A
- Pan, Dipanjan
- Lanza, Gregory M
- Weilbaecher, Katherine N
Producer: 20161020
In:
Nanomedicine : nanotechnology, biology, and medicine vol. 12
Availability: No items available.
|
|
|
13654.
|
|
|
|
13655.
|
Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study). [electronic resource] by
- Nakamura, T
- Fukunaga, M
- Nakano, T
- Kishimoto, H
- Ito, M
- Hagino, H
- Sone, T
- Taguchi, A
- Tanaka, S
- Ohashi, M
- Ota, Y
- Shiraki, M
Producer: 20180424
In:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 28
Availability: No items available.
|
|
|
13656.
|
|
|
|
13657.
|
|
|
|
13658.
|
|
|
|
13659.
|
|
|
|
13660.
|
|